- Report
- December 2024
- 82 Pages
Indonesia
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- December 2024
- 83 Pages
Saudi Arabia
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- November 2024
- 82 Pages
Vietnam
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- October 2024
- 89 Pages
Egypt
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- August 2024
- 80 Pages
Saudi Arabia
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- August 2024
- 80 Pages
Japan
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- July 2024
- 80 Pages
Japan
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- June 2024
- 85 Pages
India
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- May 2024
- 180 Pages
Global
From €3435EUR$3,825USD£2,942GBP
€4041EUR$4,500USD£3,461GBP
- Report
- May 2024
- 183 Pages
Global
From €3435EUR$3,825USD£2,942GBP
€4041EUR$4,500USD£3,461GBP
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- October 2023
- 174 Pages
Global
From €3435EUR$3,825USD£2,942GBP
€4041EUR$4,500USD£3,461GBP
- Report
- October 2023
- 84 Pages
United States
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- October 2023
- 82 Pages
Malaysia
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- October 2023
- 77 Pages
Canada
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- October 2023
- 80 Pages
Canada
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- October 2023
- 78 Pages
Ireland
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- September 2023
- 70 Pages
Israel
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- September 2023
- 72 Pages
Israel
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- September 2023
- 87 Pages
Egypt
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP

The Blood Glucose Device market is a subset of the larger Glucose Testing market. It includes products used to measure the amount of glucose in a person's blood. These devices are used by people with diabetes to monitor their blood sugar levels and adjust their insulin dosage accordingly. Blood Glucose Devices are typically small, handheld devices that use a small drop of blood to measure glucose levels. They are often used in conjunction with other diabetes management tools such as insulin pumps and continuous glucose monitors.
The Blood Glucose Device market is highly competitive, with a wide range of products available from a variety of manufacturers. Companies such as Abbott, Roche, LifeScan, and Ascensia are some of the major players in the market. Other companies such as Biosense, Sanofi, and Medtronic also offer products in this space. Show Less Read more